Grants and Contributions

The objective of this funding opportunity is to catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how (individually and in combination) the biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact in both maintaining health and in the development of disease and disability as people age.

• The Institute of Neurosciences, Mental Health and Addiction (INMHA) will fund an application that is determined to be relevant to the mandate and research priority areas of CIHR-INMHA
o The Institute of Neurosciences, Mental Health and Addiction supports (INMHA) research to enhance mental health, neurological health, vision, hearing, and cognitive functioning and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.

The objectives of this funding opportunity are to:
• Support the development, validation, harmonization and optimization of standardized methods, protocols, data collection and reporting standards as well as statistical techniques to study sex as a variable in basic cellular, tissue, and animal research at critical developmental periods including old age across broad research domains;
• Advance our understanding of basic mechanisms that drive sex differences across the lifespan;
• Support capacity building in age- and sex-related scientific techniques and grow the science among the next generation of health researchers; and
• Promote knowledge dissemination of standardized methods, protocols and techniques.

The objective of this funding opportunity is to catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how (individually and in combination) the biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact in both maintaining health and in the development of disease and disability as people age.

The Operating Grant: Methamphetamine and related psychostimulant use is expected to:

• Generate new knowledge around prevalence, incidence, and distribution of methamphetamine use in Canada
• Increase the uptake and application of synthesized knowledge in evidence-based decision-making, health care and/or health services policy and practice in this space
• Support partnerships between researchers and knowledge users to rapidly inform policies related to prevention, harm reduction, and treatment of methamphetamine use
• Address the pressing intervention-related evidence needs of knowledge users in this space
• Encourage implementation science approaches that consider sub-populations and/or the biological and social determinants of methamphetamine use

• The CIHR Institute of Infection and Immunity (CIHR-III) will offer funding for an application determined to be specifically relevant to CIHR-III broad mandate as described below:
o The Institute of Infection and Immunity (III) supports research and helps to build research capacity in the areas of infectious disease and the body's immune system. Through the Institute's programs, researchers address a wide range of health concerns related to infection and immunity including disease mechanisms, disease prevention and treatment, and health promotion through public policy.

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:
•Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
•Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
•Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.

This funding opportunity is expected to:
•Catalyze patient-oriented research aligned with the SPOR Patient Engagement Framework and SPOR Capacity Development Framework by:
¿Developing partnerships amongst patients and patient communities, researchers, health care professionals and health system decision-makers or policy-makers;
¿Mobilizing the above partnerships to develop and conduct a patient-oriented research project or projects; and,
¿Informing future applications for more comprehensive patient-oriented research grants.

To provide recognition and funding to academic researchers; to provide a reliable supply of highly skilled and qualified researchers.

This funding opportunity is expected to:
•Increase Canadian capacity to measure the impact of patient-oriented research in order to demonstrate the extent of health, social and economic benefits realized through patient-oriented research;
•Increase the literature currently available on the impact of patient-oriented research in Canada in order to:
¿Enable summative evaluation and meta-analyses on the impact of patient-oriented research; and,
¿Demonstrate how patient-oriented research compares to other health research approaches in terms of the potential to translate evidence into the health care system.